(lp0
S"TearLab Corp  Releases Earnings Results, Beats Estimates By $0.09 EPS The Cerbat Gem - 3 hours ago TearLab Corp logo TearLab Corp  issued its earnings results on Thursday. The company reported  earnings per share for the quarter, topping the Zacks' consensus estimate of  by $0.09.Latest Stocks: Chilton Investment Co. LLC Cuts Stake in TearLab Corporation  - Petro Global News 24TearLab Corporation  Broker Price Targets For The Coming Week - Fiscal Standard"
p1
aS"TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ... GlobeNewswire  - Nov 7, 2016 SAN DIEGO, Nov. 07, 2016  -- TearLab Corporation    today reported its consolidated financial results for the third quarter and nine months ended September 30, 2016.TearLab's  CEO Seph Jensen on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha"
p2
aS'Analyst Activity  Rodman &amp; Renshaw Raises Its Price Target On TearLab Corp ... Market Exclusive - Mar 10, 2017 Today, Rodman &amp; Renshaw raised its price target on TearLab Corp  to per share. There are 1 hold rating, 2 buy ratings, 1 strong buy rating on the stock.TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results - Yahoo FinanceTearLab Corp  Stock Rating Lowered by Zacks Investment Research - The Cerbat Gem'
p3
aS'TearLab Corp. MarketWatch - Dec 21, 2009 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p4
aS'TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ... GlobeNewswire  - Jul 12, 2016 SAN DIEGO, July 12, 2016  -- TearLab Corporation   , a company that develops and markets point of care ophthalmic in-vitro diagnostics, today recognized Shire plc on its recent&nbsp;...'
p5
aS"The FDA Confirms The Approval of Xiidra From TearLab Corp  Journal Transcript - Jul 15, 2016 The US Food and Drug Administration  has penned an approval of Xiidra from TearLab Corp . The FDA's action presents more options to patients suffering from dry eye disease."
p6
aS'TearLab Corporation to Report Fourth Quarter and Full-year 2016 Financial ... GlobeNewswire  - Feb 21, 2017 TearLab Corporation  develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care.In Volatile Markets Do Analysts Think You Should Buy TearLab Corporation ? - The De Soto Edge'
p7
aS'Why TearLab Corp. Shares Dipped Motley Fool - Nov 13, 2013 So what: For the quarter, TearLab reported a whopping 247% increase in revenue to $4.2 million as it received a total of 467 orders for its proprietary TearLab Osmolarity systems for diagnosing dry eye disease. Net loss also shrank modestly to just $4 ...'
p8
aS"Why This Analyst Sees TearLab Shares Tripling Benzinga - Jul 12, 2016 Rodman &amp; Renshaw's Raghuram Selvaraju mentioned that TearLab Corp 's Osmolarity System for the diagnosis of dry eye disease  is the first and only objective DED diagnostic test in the U.S."
p9
aS'TearLab Corp  Downgraded to Sell at Zacks Investment Research BNB Daily  - Mar 14, 2017 Zacks Investment Research lowered shares of TearLab Corp  from a hold rating to a sell rating in a research note issued to investors on Wednesday morning.Latest Stocks: The TearLab Corp  Receives $20.00 Average PT from Brokerages - Petro Global News 24TearLab Corp  Forecasted to Earn Q1 2017 Earnings of  Per Share - Chaffey Breeze'
p10
a.